Renerve raises AU$7M in Australian IPO for nerve repair
Renerve raises AU$7M in Australian IPO for nerve repair
Syncell raises $15M series A for precise spatial proteomics tech
Syncell raises $15M series A for precise spatial proteomics tech
Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy
Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy
Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy
Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy
Australia’s Celosia heads toward clinic with gene therapy for ALS
Australia’s Celosia heads toward clinic with gene therapy for ALS